Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CSI Announces Clinical Trials of Poet IQ Anesthesia Monitoring System.


Business Editors/Medical Writers

MILWAUKEE--(BUSINESS WIRE)--May 22, 2002

CRITICARE SYSTEMS, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (NASDAQ-NMS: CXIM) today announced participation in clinical trials of its new POET IQ(TM) anesthesia monitoring system. These trials represent the final phase prior to market release, having previously received FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approval. The core technology is the basis for six new CSI CSI Crime Scene Investigator
CSI CompuServe, Inc.
CSI Commodity Systems, Inc.
CSI Commodity Systems Inc. (Boca Raton, FL)
CSI Crime Scene Investigation (CBS TV show)
CSI Christian Schools International
 anesthesia products, all scheduled to be released within the calendar year. The operating system consists of an integrated, solid state module based on a proprietary infrared technology developed by CSI. It automatically monitors up to five anesthetic agents Anesthetic agents
Medication or drugs that can be injected with a needle or rubbed onto and area to make it numb before a surgical procedure. Anesthesia drugs may also be given by mouth, breathed in as a gas, or injected into a vein or muscle to make a patient
 plus nitrous oxide nitrous oxide or nitrogen (I) oxide, chemical compound, N2O, a colorless gas with a sweetish taste and odor. Its density is 1.977 grams per liter at STP. It is soluble in water, alcohol, ether, and other solvents. , oxygen and carbon dioxide carbon dioxide, chemical compound, CO2, a colorless, odorless, tasteless gas that is about one and one-half times as dense as air under ordinary conditions of temperature and pressure. . Additionally, the system incorporates a unique, disposable water trap component, also proprietary to CSI.

CSI President Emil Soika stated "The new POET IQ(TM) provides automatic agent recognition in a user friendly, economical package. It will be marketed as a configurable system for OEM (Original Equipment Manufacturer) The rebranding of equipment and selling it. The term initially referred to the company that made the products (the "original" manufacturer), but eventually became widely used to refer to the organization that buys the products and  applications and as a CSI branded product. We are excited about the OEM interest as well as the new market possibilities for CSI that this family of unique products allows us to participate in."

CSI (www.csiusa.com) designs, manufactures, and markets cost-effective patient monitoring systems and noninvasive sensors for a wide range of hospitals and alternate health care environments throughout the world.

This press release contains forward-looking statements. Such statements refer to the company's beliefs and expectations. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those described. Such uncertainties include, but are not limited to, the timely completion of new products, regulatory approvals for new products, the risk of new and better technologies, risks relating to international markets, as well as general conditions and competition in the company's markets. Other risks are set forth in CSI's reports and documents filed from time to time with the Securities and Exchange Commission.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CSI Announces Clinical Trials of Poet IQ Anesthesia Monitoring System.
Publication:Business Wire
Geographic Code:1U3WI
Date:May 22, 2002
Words:305
Previous Article:NE Technologies to Resell DSET's IP Solutions.
Next Article:InfraCor Acquisition of North Carolina Company Put On Hold.
Topics:



Related Articles
Criticare Systems Inc. -CSI- Announces the Introduction of the CSI-TC, a Mobile, Wireless Monitoring Station.
CSI Announces First Quarter Results.
Criticare Systems, Inc. -CSI- Announces the Grant of a Key Technology Patent for the Measurement of Blood Oxygen Saturation.
CSI Announces Marketing Agreement With Anesthesia Equipment Manufacturer, Royal Medical Co., Ltd.
Criticare Systems, Inc. - CSI - Announces FDA Approval to Market New Poet IQ Solid State Anesthetic Gas Monitor.
Aspect Medical Systems Launches Enhanced Technology, Features New Research At American Society of Anesthesiologists Meeting.
Criticare Systems, Inc. -CSI- Announces Agreement With Access Cardiosystems for Their New Automatic External Defibrillator.
Criticare Systems, Inc. Quarterly Report.
Criticare Systems, Inc. -CSI- Comment On Recent Share Price Volatility.
Anesthesia: looking back at the last century and forward to the next.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles